본문 바로가기
KERD
논문KCI 등재

Novel Approaches for Efficient Antifungal Drug Action

이동건|이희정
한국미생물·생명공학회 (The Korean Society For Microbiology And Biotechnology)|2018.11|Journal of Microbiology and Biotechnology|제28권 제11호|pp. 1771-1781

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

antimicrobial peptideAntifungal drugsprogrammed cell deathdrug combinationpolyenesazoles
주제분류생물학

초록

The emergence of multidrug-resistant microorganisms, as well as fungal infectious diseases that further threaten health, especially in immunodeficient populations, is a major global problem. The development of new antifungal agents in clinical trials is inferior to the incidence of drug resistance, and the available antifungal agents are restricted. Their mechanisms aim at certain characteristics of the fungus in order to avoid biological similarities with the host. Synthesis of the cell wall and ergosterol are mainly targeted in clinical use. The need for new approaches to antifungal therapeutic agents or development alternatives has increased. This review explores new perspectives on mechanisms to effectively combat fungal infections and effective antifungal activity. The clinical drug have a common feature that ultimately causes caspase-dependent cell death. The drugs-induced cell death pathway is associated with mitochondrial dysfunction, including mitochondrial membrane depolarization and cytochrome c release. This mechanism of action also reveals antimicrobial peptides, the primary effector molecules of innate systems, to highlight new alternatives. Furthermore, drug combination therapy is suggested as another strategy to combat fungal infection. The proposal for a new approach to antifungal agents is not only important from a basic scientific point of view, but will also assist in the selection of molecules for combination therapy.

Abstract

The emergence of multidrug-resistant microorganisms, as well as fungal infectious diseases that further threaten health, especially in immunodeficient populations, is a major global problem. The development of new antifungal agents in clinical trials is inferior to the incidence of drug resistance, and the available antifungal agents are restricted. Their mechanisms aim at certain characteristics of the fungus in order to avoid biological similarities with the host. Synthesis of the cell wall and ergosterol are mainly targeted in clinical use. The need for new approaches to antifungal therapeutic agents or development alternatives has increased. This review explores new perspectives on mechanisms to effectively combat fungal infections and effective antifungal activity. The clinical drug have a common feature that ultimately causes caspase-dependent cell death. The drugs-induced cell death pathway is associated with mitochondrial dysfunction, including mitochondrial membrane depolarization and cytochrome c release. This mechanism of action also reveals antimicrobial peptides, the primary effector molecules of innate systems, to highlight new alternatives. Furthermore, drug combination therapy is suggested as another strategy to combat fungal infection. The proposal for a new approach to antifungal agents is not only important from a basic scientific point of view, but will also assist in the selection of molecules for combination therapy.

참고문헌 (105)

  1. Campoy S, "Antifungals", Biochem. Pharmacol, 133, pp.86~96 (2017)
  2. Perfect JR., "The antifungal pipeline: a reality check", Nat. Rev. Drug Discov, 16, pp.603~616 (2017)
  3. Liu S, "Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery", Int. J. Antimicrob. Agents, 43, pp.395~402 (2014)
  4. Brown GD, "Hidden killers: human fungal infections", Sci. Transl. Med, 4, pp.165rv113~ (2012)
  5. Shor E, "A case for two-component signaling systems as antifungal drug targets", PLoS Pathog, 11, pp.e1004632~ (2015)
  6. Pierce CG, "From biology to drug development: new approaches to combat the threat of fungal biofilms", Microbiol. Spectr, 3(3) (2015)
  7. Juvvadi PR, "Calcineurin in fungal virulence and drug resistance : Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach", Virulence, 8, pp.186~197 (2017)
  8. Bassetti M, "Intensive care medicine research agenda on invasive fungal infection in critically ill patients", Intensive Care Med, 43, pp.1225~1238 (2017)
  9. Fernandez J, "Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis", Gut, 67(10), pp.1870~1880 (2017)
  10. Biswas C, "Functional disruption of yeast metacaspase, Mca1, leads to miltefosine resistance and inability to mediate miltefosine-induced apoptotic effects", Fungal Genet. Biol, 67, pp.71~81 (2014)
  11. Nett JE, "Antifungal agents: spectrum of activity, pharmacology, and clinical indications", Infect. Dis. Clin. North Am, 30, pp.51~83 (2016)
  12. Shah AH, "Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans", Biochem. J, 460, pp.223~235 (2014)
  13. Parente-Rocha JA, "Antifungal resistance, metabolic routes as drug targets, and new antifungal agents:an overview about endemic dimorphic fungi", Mediators Inflamm, 2017, pp.9870679~ (2017)
  14. Fujita K, "Anethole induces apoptotic cell death accompanied by reactive oxygen species production and DNA fragmentation in Aspergillus fumigatus and Saccharomyces cerevisiae", FEBS J, 281, pp.1304~1313 (2014)
  15. Belenky P, "Fungicidal drugs induce a common oxidative-damage cellular death pathway", Cell Rep, 3, pp.350~358 (2013)
  16. Fuentefria AM, "Antifungals discovery: an insight into new strategies to combat antifungal resistance", Lett. Appl. Microbiol, 66, pp.2~13 (2018)
  17. Teixeira-Santos R, "New insights regarding yeast survival following exposure to liposomal amphotericin B", Antimicrob. Agents Chemother, 59, pp.6181~6187 (2015)
  18. Hayes BM, "Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins", Cell Mol. Life Sci, 71, pp.2651~2666 (2014)
  19. Grudzinski W, "Molecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer", Sci. Rep, 6, pp.32780~ (2016)
  20. Chudzik B, "A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions", Eur. Biophys. J, 44, pp.77~90 (2015)
  21. Almeida B, "Drug-induced apoptosis in yeast", Biochim. Biophys. Acta, 1783, pp.1436~1448 (2008)
  22. Al-Dhaheri RS, "Apoptosis in Candida biofilms exposed to amphotericin B", J. Med. Microbiol, 59, pp.149~157 (2010)
  23. Phillips AJ, "Apoptosis induced by environmental stresses and amphotericin B in Candida albicans", Proc. Natl. Acad. Sci. USA, 100, pp.14327~14332 (2003)
  24. Guirao-Abad JP, "ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans", Int. J. Med. Microbiol, 307, pp.241~248 (2017)
  25. Folk A, "Flucytosine and amphotericin B coadministration induces dose-related renal injury", Dose Response, 15, pp.1559325817703461~ (2017)
  26. Mousavi SA, "Oxidative and amphotericin B-mediated cell death in the opportunistic pathogen Aspergillus fumigatus is associated with an apoptotic-like phenotype", Microbiology, 150, pp.1937~1945 (2004)
  27. Prasad R, "Antifungals:mechanism of action and drug resistance", Adv. Exp. Med. Biol, 892, pp.327~349 (2016)
  28. Allen D, "Azole antifungals:35 years of invasive fungal infection management", Exp. Rev. Anti Infect. Ther, 13, pp.787~798 (2015)
  29. Delattin N, "Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms", Future Med. Chem, 6, pp.77~90 (2014)
  30. Rautenbach M, "Antifungal peptides: To be or not to be membrane active", Biochimie, 130, pp.132~145 (2016)
  31. de Oliveira Pereira F, "Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum", Med. Mycol, 51, pp.507~513 (2013)
  32. Portet T, "Visualization of membrane loss during the shrinkage of giant vesicles under electropulsation", Biophys. J, 96, pp.4109~4121 (2009)
  33. Lee W, "Reactive oxygen species modulate itraconazole-induced apoptosis via mitochondrial disruption in Candida albicans", Free Radic. Res, 52, pp.39~50 (2018)
  34. Katragkou A, "Effects of fluconazole on the metabolomic profile of Candida albicans", J. Antimicrob. Chemother, 71, pp.635~640 (2016)
  35. Mahl CD, "Induction of ROS generation by fluconazole in Candida glabrata: activation of antioxidant enzymes and oxidative DNA damage", Diagn. Microbiol. Infect. Dis, 82, pp.203~208 (2015)
  36. Lee W, "A novel mechanism of fluconazole : fungicidal activity through dose-dependent apoptotic responses in Candida albicans", Microbiology, 164, pp.194~204 (2018)
  37. Feldmesser M, "The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans", J. Infect. Dis, 182, pp.1791~1795 (2000)
  38. Hao B, "Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis", Antimicrob. Agents Chemother, 57, pp.326~332 (2013)
  39. Shirazi F, "Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin nonsusceptible isolates", Virulence, 6, pp.385~394 (2015)
  40. Lakshmaiah Narayana J, "Antimicrobial peptides : possible anti-infective agents", Peptides, 72, pp.88~94 (2015)
  41. Cowen LE, "Mechanisms of antifungal drug resistance", Cold Spring Harb Perspect Med, 5, pp.a019752~ (2014)
  42. Cui J, "Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans", Virulence, 6, pp.362~371 (2015)
  43. Hagiwara D, "Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi", Front Microbiol, 7, pp.1382~ (2016)
  44. Kanafani ZA, "Antimicrobial resistance:resistance to antifungal agents: mechanisms and clinical impact", Clin. Infect. Dis, 46, pp.120~128 (2008)
  45. Shields RK, "Rate of FKS mutations among consecutive Candida isolates causing bloodstream infection", Antimicrob. Agents Chemother, 59, pp.7465~7470 (2015)
  46. Pham CD, "Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance", Antimicrob. Agents Chemother, 58, pp.4690~4696 (2014)
  47. Fekkar A, "Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin", Antimicrob. Agents Chemother, 57, pp.2380~2382 (2013)
  48. Jensen RH, "Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis", Antimicrob. Agents Chemother, 57, pp.614~617 (2013)
  49. Lee KK, "Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo", Antimicrob. Agents Chemother, 56, pp.208~217 (2012)
  50. Vincent BM, "Fitness trade-offs restrict the evolution of resistance to amphotericin B", PLoS Biol, 11, pp.e1001692~ (2013)
  51. Shlezinger N, "Apoptotic-like programed cell death in fungi: the benefits in filamentous species", Front. Oncol, 2, pp.97~ (2012)
  52. Madeo F, "Apoptosis in yeast", Curr. Opin. Microbiol, 7, pp.655~660 (2004)
  53. Murgia M, "Molecular diversity and pleiotropic role of the mitochondrial calcium uniporter", Cell Calcium, 58, pp.11~17 (2015)
  54. Carmona-Gutierrez D, "Apoptosis in yeast: triggers, pathways, subroutines", Cell Death Differ, 17, pp.763~773 (2010)
  55. Pereira C, "ADP", ATP carrier is required for mitochondrial outer membrane permeabilization and cytochrome c release in yeast apoptosis, 2007, pp.66, 571~582
  56. Shirazi F, "The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis", Eukaryot Cell, 12, pp.1225~1234 (2013)
  57. Eisenberg T, "The mitochondrial pathway in yeast apoptosis", Apoptosis, 12, pp.1011~1023 (2007)
  58. Mazzoni C, "Caspase-dependent apoptosis in yeast", Biochim. Biophys. Acta, 1783, pp.1320~1327 (2008)
  59. Costa V, "Oxidative stress and signal transduction in Saccharomyces cerevisiae: insights into ageing, apoptosis and diseases", Mol. Aspects Med, 22, pp.217~246 (2001)
  60. Ludovico P, "Yeast programmed cell death : an intricate puzzle", IUBMB Life, 57, pp.129~135 (2005)
  61. Perrone GG, "Reactive oxygen species and yeast apoptosis", Biochim. Biophys. Acta, 1783, pp.1354~1368 (2008)
  62. Leger T, "The metacaspase (Mca1p) has a dual role in farnesolinduced apoptosis in Candida albicans", Mol. Cell Proteomics, 14, pp.93~108 (2015)
  63. Kyrylkova K, "Detection of apoptosis by TUNEL assay", Methods Mol. Biol, 887, pp.41~47 (2012)
  64. Spitzer M, "Combinatorial strategies for combating invasive fungal infections", Virulence, 8, pp.169~185 (2017)
  65. Tobudic S, "In vitro activity of antifungal combinations against Candida albicans biofilms", J. Antimicrob. Chemother, 65, pp.271~274 (2010)
  66. Liao Y, "In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates", Antimicrob. Agents Chemother, 58, pp.7615~7616 (2014)
  67. Shuford JA, "In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates", Diagn. Microbiol. Infect. Dis, 57, pp.277~281 (2007)
  68. Bachmann SP, "Antifungal combinations against Candida albicans biofilms in vitro", Antimicrob. Agents Chemother, 47, pp.3657~3659 (2003)
  69. Zeng R, "In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm", Antimicrob. Agents Chemother, 58, pp.1443~1450 (2014)
  70. Garbati MA, "The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review", Int. J. Infect. Dis, 16, pp.e76~e81 (2012)
  71. Cools TL, "Antifungal plant defensins: increased insight in their mode of action as a basis for their use to combat fungal infections", Future Microbiol, 12, pp.441~454 (2017)
  72. Spanakis EK, "New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage", Clin. Infect. Dis, 43, pp.1060~1068 (2006)
  73. van der Weerden NL, "Properties and mechanisms of action of naturally occurring antifungal peptides", Cell Mol. Life Sci, 70, pp.3545~3570 (2013)
  74. Mardirossian M, "The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis", Chem. Biol, 21, pp.1639~1647 (2014)
  75. Libardo MDJ, "How does membrane oxidation affect cell delivery and cell killing?", Trends Biotechnol, 35, pp.686~690 (2017)
  76. Wang S, "Antimicrobial peptides as potential alternatives to antibiotics in food animal industry", Int. J. Mol. Sci, 17 (2016)
  77. Shivange G, "RecA stimulates AlkB-mediated direct repair of DNA adducts", Nucleic Acids Res, 44, pp.8754~8763 (2016)
  78. Roy RN, "The mechanism of inhibition of protein synthesis by the prolinerich peptide oncocin", Nat. Struct. Mol. Biol, 22, pp.466~469 (2015)
  79. Baev D, "Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans", Infect. Immun, 70, pp.4777~4784 (2002)
  80. Serhan G, "The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides", Ann. Clin. Microbiol. Antimicrob, 13, pp.18~ (2014)
  81. Semis R, "Mechanism of activity and toxicity of Nystatin-Intralipid", Med. Mycol, 51, pp.422~431 (2013)
  82. Bendaha H, "New azole antifungal agents with novel modes of action: synthesis and biological studies of new tridentate ligands based on pyrazole and triazole", Eur. J. Med. Chem, 46, pp.4117~4124 (2011)
  83. Vandenbosch D, "Fungicidal activity of miconazole against Candida spp. biofilms", J. Antimicrob. Chemother, 65, pp.694~700 (2010)
  84. Kuipers ME, "Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates", Antimicrob. Agents Chemother, 43, pp.2635~2641 (1999)
  85. Wakabayashi H, "Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents", Microbiol. Immunol, 40, pp.821~825 (1996)
  86. Vriens K, "Synergistic activity of the plant defensin hsafp1 and caspofungin against Candida albicans biofilms and planktonic cultures", PLoS One, 10, pp.e0132701~ (2015)
  87. Vriens K, "The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms", Peptides, 75, pp.71~79 (2016)
  88. Aerts AM, "The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans", FEBS Lett, 583, pp.2513~2516 (2009)
  89. Tabbene O, "Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound healing potency", J. Appl. Microbiol, 120, pp.289~300 (2016)
  90. Taveira GB, "Thionin-like peptide from Capsicum annuum fruits : mechanism of action and synergism with fluconazole against Candida species", BMC Microbiol, 16, pp.12~ (2016)
  91. 이재호, "Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle", BMB Reports, 47(11), pp.625~630 (2014), 생화학분자생물학회
  92. Lee J, "Coprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms", Free Radic. Biol. Med, 52, pp.2302~2311 (2012)
  93. Andra J, "Structure and mode of action of the antimicrobial peptide arenicin", Biochem. J, 410, pp.113~122 (2008)
  94. Cho J, "The antimicrobial peptide arenicin-1promotes generation of reactive oxygen species and induction of apoptosis", Biochim. Biophys. Acta, 1810, pp.1246~1251 (2011)
  95. Park C, "Fungicidal effect of antimicrobial peptide arenicin-1", Biochim. Biophys. Acta, 1788, pp.1790~1796 (2009)
  96. Yun J, "Cecropin A-induced a poptosis is regulated by ion balance and glutathione antioxidant system in Candida albicans", IUBMB Life, 68, pp.652~662 (2016)
  97. Wang G, "Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles", J. Biol. Chem, 283, pp.32637~32643 (2008)
  98. Pei-Wen Tsai, "Responses of Candida albicans to the Human Antimicrobial Peptide LL-37", The Journal of Microbiology, 52(7), pp.581~589 (2014), 한국미생물학회[DOI]
  99. Lee J, "Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria", caspase-dependent pathway, 2014, pp.355, 36~42
  100. Hwang B, "Induction of yeast apoptosis by an antimicrobial peptide", Papiliocin. Biochem. Biophys. Res. Commun, 408, pp.89~93 (2011)
  101. Kim JK, "Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus", J. Biol. Chem, 286, pp.41296~41311 (2011)
  102. Lee J, "Influence of the papiliocin peptide derived from Papilio xuthus on the perturbation of fungal cell membranes", FEMS Microbiol. Lett, 311, pp.70~75 (2010)
  103. Choi H, "Identification of a novel antimicrobial peptide, scolopendin 1, derived from centipede Scolopendra subspinipes mutilans and its antifungal mechanism", Insect. Mol. Biol, 23, pp.788~799 (2014)
  104. Lee H, "Scolopendin 2, a cationic antimicrobial peptide from centipede, and its membrane-active mechanism", Biochim. Biophys. Acta, 1848, pp.634~642 (2015)
  105. Lee H, "Scolopendin 2 leads to cellular stress response in Candida albicans", Apoptosis, 21, pp.856~865 (2016)

관련 논문AI추천

The Potential of Medicinal Plants in Antifungal Drug Development: Mechanisms, Synergies, and Future DirectionsMohammed Sami Farhan, Semaa A. Shaban, Yousif Nazzal Hosee대한의진균학회 · 대한의진균학회지2025 · 제30권 제1호Translational Advances in Antifungal Therapy Through Strategic Innovation in Nanocarrier and Targeted Drug Delivery SystemsShankar Ganesh M, Venkateshwaramurthy Nallasamy대한의진균학회 · 대한의진균학회지2025 · 제30권 제4호Fisetin-Mediated Perturbations of Membrane Permeability and Intracellular pH in Candida albicans김연희한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제4호Myricetin Disturbs the Cell Wall Integrity and Increases the Membrane Permeability of Candida albicans김연희, 이흥식한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제1호주요 효모균과 사상형 진균의 항진균제 내성현황신종희대한감염학회 · Infection and Chemotherapy2009 · 제41권 제2호Antifungal Activity of Salvia miltiorrhiza Against Candida albicans Is Associated with the Alteration of Membrane Permeability and (1,3)-β-D-Glucan Synthase ActivityHEUNG SHICK LEE, YOUNHEE KIM한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2016 · 제26권 제3호

이 간행물의 다른 논문 (14건)

Use of Ratiometric Probes with a Spectrofluorometer for Bacterial Viability MeasurementThomas Brauge, Guillaume Duflos, Thierry Grard, Jérôme Cléach, Philippe Lencel, Denis Watier, Bruno Le Furpp. 1782-1790Growth Performance and Post-Weaning Diarrhea in Piglets Fed a Diet Supplemented with Probiotic ComplexesMing Zhang, Xuhong Lu, Fazheng Ren, Luo Jun, Zongyi Wang, Keshan Ge, Liang Zhaopp. 1791-1799Inhibition of Human Neutrophil Elastase by Sesquiterpene Lactone Dimers from the Flowers of Inula britannica서지윤, 김대중, 이명선, 이익수, 유익동, 김관철pp. 1806-1813Synergistic Antimicrobial Effect of Lonicera japonica and Magnolia obovata Extracts and Potential as a Plant-Derived Natural Preservative이예슬, 박수남, 이윤주pp. 1814-1822Design, Optimization and Verification of 16S rRNA Oligonucleotide Probes of Fluorescence in-situ Hybridization for Targeting Clostridium spp. and Clostridium kluyveriHui Li, Rongqing Zhou, Chong-De Wu, Yao Jin, Lintao Hu, Jun Huangpp. 1822-1833
원문 보기